EN
HI
Norris Medicines Share Price
NORRIS
14.860.70 (4.94%)
Last updated on 16 Nov, 2026 | 09:44 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 16 Nov, 2026, Norris Medicines stock price is ₹14.86. During the trading session, the stock has moved between an intraday low of ₹14.00 and an intraday high of ₹14.86. Over the last 52 weeks, Norris Medicines has traded between ₹12.00 and ₹20.06.
The stock has recorded a trading volume of 14 shares,. Its Average Traded Price (ATP) is ₹14.12, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹14.86.
Norris Medicines has an upper circuit limit of ₹14.86 and a lower circuit limit of ₹13.46. The total value traded stands at ₹197.68, and the delivery percentage for the day is 78.01%.
The stock is currently traded with a market lot size of 1. Norris Medicines also offers a dividend yield of 0%.
Norris Medicines Share Price Chart
Norris Medicines Share Key Metrics
Volume
14.00
Market Cap
14.16 CR
LTQ@LTP
2@14.86
ATP
14.12
Var Margin
29.33 %
Circuit Range
13.46-14.86
Delivery %
78.01 %
Value
197.68
ASM/GSM
No
Market Lot
1
Norris Medicines Resistance and Support
Pivot 14.43
Resistance
First Resistance
14.7
Second Resistance
15.24
Third Resistance
15.51
Support
First Support
13.89
Second Support
13.62
Third Support
13.08
Norris Medicines Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
34.01%
Mutual Fund
0.01%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0.06%
Retail
65.92%
Others
0%
Total Promoters
MAR '26
34.01%
JUN '26
34.01%
SEP '26
34.01%
Norris Medicines Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-14 | Quarterly Results |
| 2026-08-14 | Quarterly Results |
| 2026-05-30 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-13 | Quarterly Results & Others |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Norris Medicines News
Norris Medicines Ltd - 524414 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday, November 14, 2026
Norris Medicines reported a 67% YoY decline in Q2 FY27 revenue to ₹65.65 lakhs. The company's net loss narrowed to ₹36.22 lakhs from a loss of ₹71.82 lakhs YoY. Half-year H1 FY27 revenue was ₹1.58 crore.
Nov 14 2026 18:02:13
Norris Medicines Ltd - 524414 - Board Meeting Intimation for Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30Th, 2026 And Other Matters.
Norris Medicines board to meet on 14 November 2026 for financial results. The meeting will be held at the registered office in Ankleshwar, Gujarat.
Nov 06 2026 11:33:33
Norris Medicines Management
| Name | Position |
|---|---|
| Vimal Shah | Executive Director |
| A Vadivel | Non Executive Independent Director |
Norris Medicines Similar Stocks
Venmax Drugs And Pharmaceuticals Ltd.
14.40
-0.62 (4.13%)
Beryl Drugs Ltd.
26.39
2.13 (8.78%)
Sharma East India Hospitals & Medical Research Ltd
84.99
4.79 (5.97%)
Soni Medicare Ltd.
66.00
0.00 (0.00%)
Parmax Pharma Ltd.
136.35
1.35 (1.00%)
Colinz Laboratories Ltd.
72.00
0.00 (0.00%)
Broach Lifecare Hospital Ltd.
12.70
0.00 (0.00%)
Starsource Multitrade Ltd.
96.55
0.00 (0.00%)
Norris Medicines FAQs
The Buying Price of Norris Medicines share is 14.86 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Norris Medicines stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Norris Medicines, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Norris Medicines shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Norris Medicines shares is 0. Useful to assess the stock's value relative to its book value.
To assess Norris Medicines’s valuation compare Sector P/E, P/B which are 41.18 & 2.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Norris Medicines is 14.16 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Norris Medicines share price is 20.06 & 12.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Norris Medicines belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in NORRIS
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC